Need for Active Left-Ventricular Decompression during Percutaneous Cardiopulmonary Support in Cardiac Arrest

During ventricular fibrillation, myocardial hemodynamic and metabolic effects of percutaneous cardiopulmonary support (PCPS) were analyzed in 11 adult sheep (body weight 77-112 kg). During supported fibrillation, an abrupt increase in left-ventricular pressures with alignment to aortic pressures was observed in 2 animals, which was probably due to spontaneous aortic regurgitation, and resulted in deterioration of coronary perfusion. In 9 animals, left-ventricular pressures rose from 22.9 ± 4.9 to 31.2 ± 7.9 mm Hg elevating left ventricular wall stress from 16,750 ± 8,745 to 28,835 ± 8,892 dyn/cm2 after 10 min of PCPS-supported fibrillation (mean flow rate 4.5 ± 0.7 liters/min). Simultaneously, myocardial perfusion pressures decreased from an average of 32.4 ± 11.7 to 22.3 ± 9.4 mm Hg and myocardial lactate release was observed. Additional transapical LV venting using a 9-Fr catheter led to a decrease in both LV pressure (to 25.7 ± 5.3 mm Hg) and wall stress (to 20,612 ± 7,499 dyn/cm2). Left-ventricular decompression decreased myocardial oxygen consumption (from 5.3 ± 1.4 to 4.8 ± 0.9 ml/min· 100 g), and reduced myocardial lactate release, which indicates myocardial protection. Protective effects were most pronounced using 12-Fr-, and 21-Fr-venting cannulas (with 21 Fr: decrease in myocardial oxygen consumption to 2.7 ± 0.6 ml/min· 100 g, and reversal of myocardial lactate release to lactate uptake during fibrillation).Conclusions.Hemodynamic and metabolic data clearly demonstrate the deleterious effects of PCPS to the unvented left ventricle during cardiac arrest. The results emphasize the need for active left-ventricular decompression during PCPS in ventricular fibrillation.